ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) is a blank check company sponsored by ARYA Sciences Management IV LLC, an affiliate of Perceptive Advisors, a New York-based healthcare-focused investment manager. The company completed its initial public offering in 2021, targeting opportunities in the life sciences and biotechnology sector. ARYD filed its annual report on Form 10-K with the SEC on March 29, 2024, indicating the company remained in its search phase for a qualifying business combination as of that date. The ARYA Sciences franchise has launched four SPACs, each focused exclusively on healthcare and life sciences targets consistent with Perceptive Advisors' core investment mandate. For full filing history, deal timelines, and SPAC analytics on ARYD, sign up for complete data access at SpacDesk.